211 related articles for article (PubMed ID: 27939675)
1. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections.
Cruz-Muñiz MY; López-Jacome LE; Hernández-Durán M; Franco-Cendejas R; Licona-Limón P; Ramos-Balderas JL; Martinéz-Vázquez M; Belmont-Díaz JA; Wood TK; García-Contreras R
Int J Antimicrob Agents; 2017 Jan; 49(1):88-92. PubMed ID: 27939675
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.
Arivett BA; Fiester SE; Ohneck EJ; Penwell WF; Kaufman CM; Relich RF; Actis LA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7657-65. PubMed ID: 26416873
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
Hornsey M; Phee L; Longshaw C; Wareham DW
Int J Antimicrob Agents; 2013 Mar; 41(3):285-7. PubMed ID: 23312607
[TBL] [Abstract][Full Text] [Related]
4. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
6. In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
Yang H; Chen G; Hu L; Liu Y; Cheng J; Li H; Ye Y; Li J
Int J Antimicrob Agents; 2015 Feb; 45(2):188-91. PubMed ID: 25440154
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
[TBL] [Abstract][Full Text] [Related]
9. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
[TBL] [Abstract][Full Text] [Related]
10. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.
Hornsey M; Wareham DW
Antimicrob Agents Chemother; 2011 Jul; 55(7):3534-7. PubMed ID: 21502628
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
13. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
Wei W; Yang H; Hu L; Ye Y; Li J
J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.
Antunes LC; Imperi F; Minandri F; Visca P
Antimicrob Agents Chemother; 2012 Nov; 56(11):5961-70. PubMed ID: 22964249
[TBL] [Abstract][Full Text] [Related]
15. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
[TBL] [Abstract][Full Text] [Related]
16. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
[TBL] [Abstract][Full Text] [Related]
17. Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.
Wand ME; Bock LJ; Bonney LC; Sutton JM
J Antimicrob Chemother; 2015 Aug; 70(8):2209-16. PubMed ID: 25904728
[TBL] [Abstract][Full Text] [Related]
18. Variation in formation of persister cells against colistin in Acinetobacter baumannii isolates and its relationship with treatment failure.
Chung ES; Wi YM; Ko KS
J Antimicrob Chemother; 2017 Jul; 72(7):2133-2135. PubMed ID: 28379382
[No Abstract] [Full Text] [Related]
19. Antibacterial properties of phenothiazine derivatives against multidrug-resistant Acinetobacter baumannii strains.
Aguilar-Vega L; López-Jácome LE; Franco B; Muñoz-Carranza S; Vargas-Maya N; Franco-Cendejas R; Hernández-Durán M; Otero-Zúñiga M; Campo-Beleño C; Jiménez-Cortés JG; Martínez-Vázquez M; Rodríguez-Zavala JS; Maeda T; Zurabian R; García-Contreras R
J Appl Microbiol; 2021 Nov; 131(5):2235-2243. PubMed ID: 33884726
[TBL] [Abstract][Full Text] [Related]
20. Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii.
Gebhardt MJ; Gallagher LA; Jacobson RK; Usacheva EA; Peterson LR; Zurawski DV; Shuman HA
mBio; 2015 Nov; 6(6):e01660-15. PubMed ID: 26556274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
